| 131 |
Development of an innovative turn-on fluorescent probe for targeted in-vivo detection of nitric oxide in rat brain extracts as a biomarker for migraine disease |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 132 |
Development of Highly Sensitive Fluorescent Sensors for Separation-Free Detection and Quantitation Systems of Pepsin Enzyme Applying a Structure-Guided Approach |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 133 |
Development of Oral Formulation of Lepidium Seeds Significantly Decreases the High Blood Glucose Levels in Diabetic Rats; In Vitro Formulation and In Vivo Antidiabetic Performance. |
Department of Industrial Pharmacy |
2024 |
| 134 |
Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and Topoisomerase IV inhibitors endowed with antibacterial properties |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 135 |
Dual emission BSA-capped bimetallic nanoclusters for detection of acrylamide in certain food matrices based on thiol-ene Michael addition click reaction |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 136 |
Dual-Modulation ratiometric fluorescence strategy for cobalt and topotecan detection using Red-Emissive carbon dots |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 137 |
Electrochemical Sensor Based on Molybdenum-Doped Graphene Oxide Nanorods Anchored Carbon Spheres/Vanadium Pentoxide Nanocomposites for Simultaneous Determination of Diclofenac Sodium and Posaconazole |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 138 |
Electrospun Tamarindus indica-loaded antimicrobial PMMA/cellulose acetate/PEO nanofibrous scaffolds for accelerated wound healing: In-vitro and in-vivo assessments |
Department of Pharmacognosy |
2024 |
| 139 |
Enhanced dual fluorescence quenching of red and blue emission carbon dots by copper dimethyldithiocarbamate for selective ratiometric detection of ziram in foodstuff and water samples |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 140 |
Enhanced fluorescent detection of oxaliplatin via BSA@ copper nanoclusters: a targeted approach for cancer drug monitoring |
Department of Pharmaceutical Analytical Chemistry |
2024 |